CALCRL and migraine disorder: Antibody- or small molecule-based targeting of the CALCRL ligand calcitonin gene-related peptide (CGRP) are currently being investigated for migraine (NCT03432286, NCT05217927) and may warrant investigation as novel agents for both adult and pediatric AML.